, related to Figure 1 . A genome-wide siRNA screen for regulators of mitotic cell fate. (A) Workflow of the screen. (B) Result of the primary screen, plotting the robust Z scores (Z*) for the two replicates. Z* scores were calculated using the median absolute deviation for each plate (Chung et al., 2008) . Genes with mean Z* scores greater than 3 were taken forward to the secondary screen. (C) Fate profiles of RKO cells transfected with selected ON-TARGETplus SMARTpools and exposed to 0.1 µM taxol. (D) Bar graph showing viability of taxol-treated RKO cells after transfection of individual siRNAs from the SMARTpools used in the 1 o and 2 o screens. While siRNAs in many of the siGENOME and ONTARGETplus SMARTpools are distinct, in some instances there is duplication, indicated by hashtags (#) and paragraph symbols ( ¶). Myc siRNAs 4, 5, 6 and 8 repress Myc and inhibit death in mitosis (DiM) (Fig. S2A ) so they were pooled and used for further experiments, while #4 was used in isolation for the RNAi-rescue experiment in Fig. S2B . Values represent mean and SD from two experiments. (E) Boxand-whisker plots (median, interquartile and 10-90% ranges) showing that in isolation, SNTA1 #4 and ZNF791 #1 accelerate mitotic exit. In contrast, the active KCNK1 siRNA more closely resembles the Myc phenotype. Table S1 Fig. 4D . Middle panel shows that tet-induction of Bcl-xL blocks apoptosis in the presence of 10 nM taxol but that this is reverted by titrating in the Bcl-xL inhibitor WEHI-539. 100 nM was selected for the experiment in Fig. 4D . Right panel shows that in the absence of antimitotic agents, while 10 µM WEHI-539 induces apoptosis, 100 nM is relatively benign. Notes: The volcano plot (Fig. S5A ) visualises the correlation of drug sensitivity data with genetic events calculated using a multivariate ANOVA. Gene specific volcano plots represent the effect of a mutated gene (e.g. BRAF) on the responses to all drugs analysed. The volcano plot presents three pieces of data:
• x-axis: The magnitude of the effect that genetic events have on cell lines IC 50 values in response to a drug. IC 50 values were correlated with the status of commonly altered cancer genes using a two way multivariate ANOVA, with mutation status and tissue type as factors. The effect size is proportional to the difference in mean IC 50 between wild-type and mutant cell lines. Numbers less than 1 indicate drug sensitivity, numbers greater than 1 indicate drug resistance.
• y-axis: The p-value from the MANOVA of a drug-gene interaction on an inverted log10 scale.
• Size of each circle: The number of genetic events contributing to the analysis for a given gene or drug.
(See www.cancerrxgene.org for more details.) Table S6 -2.54 -1.86 -3.28 -2.11 -2.79 -3.60 -3.22 -2.21 -3.74 -1.48 -0.57 -1.59 -0.90 -1.20 -0.28 -0.27 -0.15 -0.15 -1.14 -3.36 -1.12 -3.17 -1.57 -3.14 -1.96 -3.47 -4.38 -3.12 -1.11 -3.49 -1.33 -1.37 -0.85 -1.78 -1.45 -0.97 -1.35 (Ditchfield et al., 2003) , also reduces DiM in the absence taxol, to 34%. Note that Aurora B promotes telomere deprotection upon mitotic entry, activating a DNA damage signal (Hayashi et al., 2012) . (D) Characterisation of a tet-inducible RKO cell line overexpressing the shelterin component TRF2, tagged with an N-terminal Myc epitope.
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Immunoblot shows induction of TRF2 with 1 µg/ml tetracycline and growth curves shows that, in the absence of taxol, this does not inhibit proliferation.
Supplemental Experimental Procedures
Cell lines
Colon carcinoma lines (RKO, DLD-1, HCT116, HT29), lung carcinoma lines (Calu6 and H1703) breast (MDA-MB-231) and ovarian cancer lines (SKOV3, PA1, SW626, Caov3) were obtained from the American Type Culture Collection. HeLa cells were as described (Taylor and McKeon, 1997) , HCT116 p53 -/-were provided by Bert Vogelstein (Bunz et al., 1998) . Cells were cultured in DMEM plus 10% fetal calf serum (LifeTechnologies), 2 mM glutamine, 100 U/ml penicillin, and 100 U/ml streptomycin (Lonza). For PA1, SW626 and SKOV3, DMEM was replaced by Minimum Essential Media, Leibovitz's L-15 (Sigma-Aldrich) and McCoys (modified) 5A medium (Life Technologies) respectively. All lines were grown at 37 o C in a humidified 5% CO 2 incubator. For the tertiary screen, we use an RKO line expressing a GFP-tagged histone H2B (Gascoigne and Taylor, 2008) so that mitotic index could be approximated by measuring the granularity of the chromatin.
siRNA sequences
The sequences of siRNAs used in this study are listed below. All siRNAs were from Dharmacon unless stated otherwise.
